| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Connect Biopharma Holdings Limited (NASDAQ: CNTB)
CNTB Technical Analysis
5
| As on 9th Jun 2023 CNTB STOCK Price closed @ 1.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.19 & Strong Sell for SHORT-TERM with Stoploss of 4.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CNTBSTOCK Price
| Open | 1.07 | Change | Price | % |
| High | 1.12 | 1 Day | -0.02 | -1.80 |
| Low | 1.07 | 1 Week | -0.07 | -6.03 |
| Close | 1.09 | 1 Month | 0.06 | 5.83 |
| Volume | 93733 | 1 Year | -3.45 | -75.99 |
| 52 Week High 5.92 | 52 Week Low 0.56 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CNTB Daily Charts |
CNTB Intraday Charts |
Whats New @ Bazaartrend |
CNTB Free Analysis |
|
|
CNTB Important Levels Intraday
| RESISTANCE | 1.19 |
| RESISTANCE | 1.16 |
| RESISTANCE | 1.14 |
| RESISTANCE | 1.12 |
| SUPPORT | 1.06 |
| SUPPORT | 1.04 |
| SUPPORT | 1.02 |
| SUPPORT | 0.99 |
CNTB Forecast May 2024
| 4th UP Forecast | 4.42 |
| 3rd UP Forecast | 3.35 |
| 2nd UP Forecast | 2.69 |
| 1st UP Forecast | 2.03 |
| 1st DOWN Forecast | 0.15 |
| 2nd DOWN Forecast | -0.51 |
| 3rd DOWN Forecast | -1.17 |
| 4th DOWN Forecast | -2.24 |
CNTB Weekly Forecast
| 4th UP Forecast | 4.02 |
| 3rd UP Forecast | 3.08 |
| 2nd UP Forecast | 2.50 |
| 1st UP Forecast | 1.92 |
| 1st DOWN Forecast | 0.26 |
| 2nd DOWN Forecast | -0.32 |
| 3rd DOWN Forecast | -0.90 |
| 4th DOWN Forecast | -1.84 |
CNTB Forecast2024
| 4th UP Forecast | 11.55 |
| 3rd UP Forecast | 8.2 |
| 2nd UP Forecast | 6.12 |
| 1st UP Forecast | 4.05 |
| 1st DOWN Forecast | -1.87 |
| 2nd DOWN Forecast | -3.94 |
| 3rd DOWN Forecast | -6.02 |
| 4th DOWN Forecast | -9.37 |
Connect Biopharma Holdings Limited ( NASDAQ USA Symbol : CNTB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CNTB Business Profile
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China. Address: East R&D Building, Taicang, China, 215400
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service